BIONSIL
BiOnSil is a spin-off of the University of Milan-Bicocca, developing diagnostic and theranostic kits for the diagnosis of drug resistance in colorectal cancer; further down the product pipeline are also pharmacological inhibitors that could reduce carcinoma pharmacoresistance. The product platform is based on the researches of the team, that led to the identification of specific genes involved in drug resistance of colorectal cancer
BIONSIL
Industry:
Health Diagnostics Therapeutics
Address:
Milan, Lombardia, Italy
Country:
Italy
Status:
Active
Total Funding:
3 M EUR
Similar Organizations
Precision Biologics
Precision Biologics develops therapeutic and diagnostic products for the early detection and treatment of cancer.
Current Employees Featured
Investors List
Green Arrow Capital
Green Arrow Capital investment in Venture Round - BiOnSil